SEATTLE GENETICS INC /WA (SGEN) has 587 open-market insider trades by 39 insiders since 2006. The most active filer is Clay B. Siegall, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Felix Baker | Dir10% Owner | — | 40 | $1.1B | 2022-03-08 |
| Baker Brothers Life Sciences LP | Dir10% Owner | — | 10 | $588.1M | 2021-12-01 |
| 667, L.P. | Dir10% Owner | — | 22 | $506.4M | 2023-12-14 |
| Clay B. Siegall | CEOPres | — | 117 | $237.7M | 2022-05-12 |
| BAKER Bros. Advisors L.P. via Julian Baker | Dir10% Owner | — | 5 | $153.8M | 2023-05-31 |
| Baker Bros. Advisors (GP) LLC via Felix Baker | Dir10% Owner | — | 5 | $136.9M | 2017-05-15 |
| Julian Baker | Dir10% Owner | — | 41 | $131.4M | 2022-05-13 |
| 14159, L.P. | Dir10% | — | 3 | $120.2M | 2014-12-10 |
| Brothers Life Sciences Capital (gp) Llc Baker | Dir10% | — | 12 | $88.3M | 2011-08-25 |
| Todd E. Simpson | CFO | — | 36 | $72.0M | 2023-12-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David R. Epstein | CEO | Sell | $4.5M | 2023-11-10 |
| Vaughn B. Himes | CTO | Sell | $3.7M | 2023-11-09 |
| Todd E. Simpson | CFO | Sell | $17K | 2023-09-21 |
| Charles R. Romp | EVP & Commercial U.S. | Sell | $9K | 2023-09-21 |
| Jean I. Liu | CLO | Sell | $13K | 2023-09-21 |
| Roger D. Dansey | President & R&D & CMO | Sell | $15K | 2023-09-21 |
Companies that share insiders with SGEN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Vaughn B. Himes | CTO | Sell | $3.6M | 2023-09-07 |
| Roger D. Dansey | President & CMO | Sell | $1.7M | 2023-08-31 |
| Vaughn B. Himes | CTO | Sell | $743K | 2023-08-31 |
| Charles R. Romp | VP | Sell | $230K | 2023-08-31 |
| Jean I. Liu | CLO | Sell | $784K | 2023-08-31 |
| Todd E. Simpson | CFO | Sell | $878K | 2023-08-31 |
| Todd E. Simpson | CFO | Sell | $100K | 2023-08-29 |
| Roger D. Dansey | President & CMO | Sell | $209K | 2023-08-29 |
| Jean I. Liu | CLO | Sell | $83K | 2023-08-29 |